Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Early diagnosis and treatment by vets are crucial for managing rare but severe feline skin disorders.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Cemiplimab can cause alopecia areata, but it can be treated successfully.

Chronic inflammatory skin disorders are caused by immune system problems, not just skin issues.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

A gel from stem cells can reduce baldness caused by fluconazole in rats.

Mesenchymal stem cell secretome shows promise for skin treatments but needs more human trials.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

3D spheroid cultures of human hair follicle cells are better for hair growth research than 2D cultures, and they provide new insights into how hair growth treatments like minoxidil and TCQA work.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Cellular senescence is crucial for normal embryonic development but contributes to aging in adults.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

PRP and ADSC therapies show promise in improving symptoms of genital lichen sclerosus with minimal side effects.

Patients with hidradenitis suppurativa have higher levels of cell-free DNA in their blood.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Restoring hair follicle immune privilege may help treat alopecia areata.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

Squaric acid dibutylester helps hair growth by increasing certain immune cells in the skin.